Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed the stock exchanges about three upcoming investor meetings scheduled in September 2025. On September 3, the company will attend the Elara Investor Conference 2025 in Mumbai. On September 18, it will participate in the Kotak Healthcare Forum 2025, also in Mumbai. On September 23, the company will be at the DAM Capital Pharmaceutical Conference 2025 in Mumbai. All meetings will be conducted physically and will include both group and one-on-one sessions. The company clarified that no Unpublished Price Sensitive Information (UPSI) will be shared at these meetings.
This is a routine regulatory disclosure about scheduled investor interactions and is unlikely to have a direct impact on the stock price. It signals normal investor engagement activity by the company.